Enhancing insulin sensitivity and regulating glucose homeostasis are equally essential for restoring metabolic balance and addressing the systemic metabolic dysregulation commonly associated with MASH and MASLD. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.